High convergence of molecular diagnostics and big data analytics will enable predictive analytical capabilities for diagnostic platforms. Several in vitro diagnostic (IVD) companies are expanding their product portfolios to include liquid biopsy and companion diagnostics (CDx) in their long-term strategies. Our research coverage includes tissue diagnostics, liquid biopsy, digital pathology and pre-natal diagnostics and biomarkers for combination therapies.
Know anyone building innovative solutions that belong in this 'Molecular Diagnostics & Companion Diagnostics'?
Over the past two decades, advances in transcriptomic methods have led to the discovery of a very rich and diverse set of RNA transcripts, short and long, that serve as regulators rather than templates for protein production. Many of these transcribed elements are encoded in noncoding regions of the genome with other regulatory and structural DNA elements of known and unknown functions. Often these important problems are tackled and discussed within different sub-communities, including the mature fields of microRNAs (miRNAs) and piRNAs, and the emerging fields focused on longer linear noncoding RNAs (lncRNAs), circular RNAs (circRNAs), and other, non-transcribed yet functional genomic elements. This symposium traditionally brings together members of these communities, enabling researchers focusing on different classes of non-coding elements to interact and learn from each other. We are pleased to return to doing this at an in-person meeting this year, following the virtual edition held in 2021. For 2023, the main pillars of the meeting will remain, with sessions on miRNAs, piRNAs, lncRNAs and circRNAs, alongside sessions showcasing less RNA-centric fields, such as heterochromatin and telomere biology, and transcribed regulatory regions.
This is a great opportunity to explore and enhance great arguments in the field of Personalized Medicine. This will be a great occasion to meet Delegates, keynote speakers, students from universities, scientists, professors, Cardiologists, Nurses, Pharmacists, Nano technologists, directors, and Business delegates at the webinar to exchange scientific ideas and experiences in a distinctive environment and share your thoughts and suggestions to all the participants.
ONCOMPASS™ Full is a premier molecular diagnostic and therapeutic information service. It includes a cutting edge molecular diagnostic of up to 60 therapeutically relevant genes from the tumor, using …
The assurance cookie is found and is being filtered in Google Analytics.
These cookies are used to collect information about how you interact
with our website and allow us to remember you. We use this
information in order to improve and customize your browsing
experience, and for analytics and metrics about our visitors both on
this website and other media. To find out more about the cookies we
use, see our